/channels/taxonomy/term/10023/all en /channels/channels/news/breakthrough-ms-treatment-264891 <p><strong>Drug shown to reduce new attacks/symptom progression in some patients</strong></p> <p>In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.</p> Thu, 22 Dec 2016 20:31:29 +0000 webfull 123839 at /channels /channels/news/breakthrough-ms-treatment-264980 <p>In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.</p> <p>Three studies conducted by an international team of researchers, which included Amit Bar-Or and Douglas Arnold from the Montreal Neurological Institute and Hospital of ºÚÁϲ»´òìÈ University, have discovered that ocrelizumab can significantly reduce new attacks in patients with relapsing MS, as well as slow the progression of symptoms caused by primary progressive MS.</p> Mon, 09 Jan 2017 15:47:40 +0000 webfull 123953 at /channels